United States (US) domiciled, $250m closed-end Special Situation fund targets 25%+ net Internal Rate of Return (IRR) by investing $20m to $25m in 10 to 12 portfolio companies each with targeted investment returns of 3x to 6x in a period of three to four years. Performance compares to historic 20-year venture returns.

Management applies personalized venture capital approach, building shareholder value through organic growth and strategic mergers of synergistic late-stage private and public microCap companies to help the microCap grow to smallCap status and to attract substantial investor attention.

Focused on US segments of the software, semiconductor and medical devices technology industries where management has over 60 total years operating experience (including four full-time and two interim CEO assignments) and over 45 total years venture investment experience.

Prior funds performed in the top quartiles of the respective vintage years. Collectively the Team has invested $230m and returned over $1.4b in 42 positive exits (24 Initial Public Offerings) from 85 investments.